Vantage Health/ STSI Press Release
Vantage Health and Scripps Translational Science Institute are developing point-of-care chemical sensor apps.
STSI will help validate the sensors, which can detect basic volatile organic compounds by using gas chromatography and mass spectrometry. They intend to use the sensor to detect VOCs commonly associated with lung cancer.
Last month Vantage Health partnered with NASA to commercialize its patents in nanotechnology, chemical sensing, carbon nanotubes, medical diagnoses, and environmental sensing as mobile health products. Their stated initial application was lung cancer.
Leave a Reply